Dauricine combined with clindamycin inhibits severe pneumonia co-infected by influenza virus H5N1 and Streptococcus pneumoniae in vitro and in vivo through NF-κB signaling pathway
Authors:
Open Access
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 137 (1) , 12-19
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Excess mortality associated with influenza after the 2009 H1N1 pandemic in a subtropical city in China, 2010–2015International Journal of Infectious Diseases, 2017
- Qingfei Xiaoyan Wan, a traditional Chinese medicine formula, ameliorates Pseudomonas aeruginosa–induced acute lung inflammation by regulation of PI3K/AKT and Ras/MAPK pathwaysActa Pharmaceutica Sinica B, 2016
- Influenza A and methicillin-resistant Staphylococcus aureus co-infection in rhesus macaques – A model of severe pneumoniaAntiviral Research, 2016
- Potentiation activity of multiple antibacterial agents by Salvianolate from the Chinese medicine Danshen against methicillin-resistant Staphylococcus aureus (MRSA)Journal of Pharmacological Sciences, 2016
- Anti-inflammatory effects of glaucocalyxin B in microglia cellsJournal of Pharmacological Sciences, 2015
- Genetic tuning of avian influenza A (H7N9) virus promotes viral fitness within different speciesMicrobes and Infection, 2015
- Osthole attenuates the development of carrageenan-induced lung inflammation in ratsInternational Immunopharmacology, 2014
- Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF‐κB signaling pathway in colon cancer cellsJournal of Cellular Physiology, 2010
- Of mice and men: innate immunity in pneumococcal pneumoniaInternational Journal of Antimicrobial Agents, 2010
- Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infectionJournal of Medical Virology, 2006